Plain-English translation of NCT00948116 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking for new biological markers—essentially early warning signs in your blood and urine—that could help doctors predict kidney injury before it happens. People with diabetes who are having a planned heart procedure (called a coronary intervention) are at higher risk of kidney damage from the contrast dye used during the procedure, and this research aims to catch that damage much earlier than current tests allow.
Currently, doctors rely on a blood test called creatinine to check kidney function, but this test often shows problems too late. This study exists because there is an urgent need to find new, faster warning signs so doctors can protect kidney health in diabetic patients having heart procedures—a group at particularly high risk.
You likely qualify if…
You likely don't qualify if…
You would participate as part of your already-planned heart procedure—no extra visits or interventions are required. Before and after your heart procedure, researchers will collect blood and urine samples from you, and they will review your medical records to gather relevant health information. The study follows patients like you to see who develops kidney injury and to identify which biological markers in the blood and urine best predict this risk early on.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
United Kingdom
Sponsor
Barts & The London NHS Trust
Enrollment target
~250 participants
Started
June 2009
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
AKHIL KAPUR
CONSULTANT CARDIOLOGIST AND HONORARY SENIOR LECTURER, BARTS AND THE LONDON NHS TRUST
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.